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Abstract
Scientific publications should provide sufficient detail in terms of methodology and presented data
to enable the community to reproduce the methodology to generate similar data and arrive at the
same conclusion, if an identical sample is provided for analysis. The advent of high-throughput
methods in biological experimentation impose some unique challenges both in data presentation in
classical print format, as well as in describing methodology and data analysis in sufficient detail to
conform to good publication practice. To facilitate this process, Proteome Science is adopting a set
of methodology and data presentation guidelines to enable both peer reviewers, as well as the
scientific community, to better evaluate high-throughput proteomic studies.
Editorial
Historically, most scientific publications included a
detailed methodology section that provided details on
source of reagents, information, such as batch or lot num-
bers, and a description of methodology that would enable
another research group to follow the same procedures.
Given the same starting material, this practice would
allow arriving at identical or very similar data. At the very
least, methodology sections should refer to prior publica-
tions that provide sufficient experimental detail to allow
the reproduction of scientific experiments. Most publica-
tions would then display "typical" results, such as photo-
graphs or micrographs of the experimental subject, images
of detected molecules, or minimally processed data, such
as statistically evaluated graphs or tables. These results
were displayed together with negative and often positive
controls that validate the experiment and reagents. The
printed media was mostly adequate to publish these stud-
ies, because most studies investigated individual phenom-
ena or molecules.
The advent of high-throughput methods in biological
experimentation have imposed some unique challenges
both in data presentation in classical print format, as well
as in describing the methodology and data analysis work-
flow in sufficient detail to conform to good publication
practice. This especially is an issue with proteomic analy-
ses conducted by mass spectrometry [1,2]. Electronic
media and public repositories are addressing the need for
publishing uninterpreted data sets [3-5], such as raw or
minimally processed mass spectrometer data, as well as
lists of identified peptides. The remaining challenge is in
the generation of ontologies and common experimental
descriptions that capture the wealth of information that
has both gone into the design and the analysis of pro-
teomic experiments. This ultimately is needed when
directly comparing multi-centre studies.
Much progress has been made by the community to pro-
pose data format standards that are compatible with most
if not all analytical platforms [5,6]. However, there
appears to be less conformity in the community when
deciding what are minimal publication standards for such
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mally rigorous enough to weed out submissions that are
considered poor quality due to study design, choice of
methods, or overall data quality. Unfortunately, depend-
ent on the expertise of the peer reviewer, methodological
detail is sometimes not considered as much as it should.
While in the short term these studies will have their place
in the community, in the long term they may not be con-
sidered valid because of lacking descriptive detail.
To ensure that studies of this nature withstand the test of
time, Proteome Science has adopted a set of methodology
and data presentation guidelines to enable both peer
reviewers, as well as the scientific community, to better
evaluate high-throughput proteomic studies leading to
peptide and protein identification. These guidelines are by
no-means top-down guidelines to restrict publication;
instead, they are meant to reflect the accepted community
standards in the field. As always with community guide-
lines, the publication guidelines proposed by the HUPO
Proteomics Standards Initiative [7] will hopefully help to
enable our authors to withstand the critique by the pro-
teomics community over time. They are in no way
intended to impose a standardized method to conduct
experiments, which would be counterproductive to this
still emerging and exciting field. We expect our authors to
adhere to good scientific practise, such as listing source
materials, methods of sample processing, the precise con-
ditions to which samples were exposed prior to sampling,
and the number of times an experiment has been con-
ducted. In addition, if the authors use mass spectrometry
to identify proteins in their samples, we recommend the
adherence to the following guidelines to allow re-interpre-
tation of the experimental data and comparison to other
studies.
The following publication guidelines for the reporting
and documentation of mass spectrometer-based peptide
and protein identifications have in part been proposed by
the HUPO Proteomics Standards Initiative [7,8]. They
were heavily consulted during the development of publi-
cation recommendations for Proteome Science:
(a) Supporting information to be included in submitted
manuscript:
1. Make, model, and version number of mass spectrome-
ter, version of operating software, detailed acquisition
parameters, and performance specs, such as resolution,
sensitivity and dynamic range. If LC-MS/MS was per-
formed, make, model, and version of HPLC system, oper-
ating specs on flow rate, gradients and columns used.
Details on ionization source and conditions. Number of
times experiment has been performed, and concordance
between experiments.
2. The method(s), software (including version number)
used to create the peak list from raw spectra, and the per-
tinent parameters used in the creation of the peak list. If
custom algorithms or software were used to compile the
list, these need to be listed in detail. Examples include
parameters, such as smoothing, signal-to-noise ratio,
whether charge states were calculated or peaks de-iso-
toped. In cases where additional customized processing of
peak lists have been performed, such as clustering or filter-
ing, the algorithm or software (including version) must be
referenced or described.
3. The application and version number used for database
searching, as well as the search parameters. Examples
include precursor-ion mass tolerance, fragment-ion mass
tolerance, fixed and variable modifications allowed for,
number of missed cleavages, protein cleavage agents, iso-
topic or isobaric tagging chemistry, and so on.
4. The name and version of the sequence database and
sequence space searched, including details on taxonomy
and other search restrictions. If the database was custom
compiled, a complete description of the sequence source
is needed, and if not easily reproducible, a provision for
making the database publicly available is needed. The
number of entries actually searched from each database
should be included. Authors should justify the use of very
small databases, since this may generate misleading
assignments. Common contaminants (keratins, trypsin)
should be included in the database.
5. Methods used to interpret MS/MS data, thresholds and
values specific to judging probability of identification, sta-
tistical methods used, and description of how analysis was
validated, need to be described.
6. For large projects (e.g. mapping or comparison between
complex fractions), additional statistical details should be
listed, as they are pertinent to identification certainty,
determination of false-positive rate, randomized database
validation, or other computational approaches.
(b) When compiling information for protein identifica-
tions, the following information should be included:
1. Accession number and database source.
2. Score(s) and any statistical information for searches
conducted.
3. Sequence coverage, expressed as the number of amino
acids spanned by the assigned peptides by the intact pro-
tein's length.Page 2 of 3
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4. The total number of peptides assigned to the protein.
To compute this number, different forms of the same pep-
tide are to be counted as one peptide.
(c) When presenting relative and absolute quantification
data, the following information should be listed in addi-
tion to the information in section (b):
1. Quantification methods used and labelling conditions,
if any.
2. Calibration standards used, if any.
3. Algorithms, software, and method details on how
quantitative data was obtained.
4. Concordance and variance for different peptides from
same protein, and method used to average individual pep-
tides for a given protein.
5. Additional statistical information, such as p-values of
quantified proteins, and common variance between
experimental repeats.
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